EU’s Northern Ireland Drug Supply Solution Imminent
Executive Summary
The European Commission’s legislative proposal will close the gaps in medicines regulation caused by Brexit and the Northern Ireland Protocol.
You may also be interested in...
Industry Warns Of New Post-Brexit ‘Cliff Edge’ For Medicines Supply To Northern Ireland
The burden of having to produce separate product packs for Great Britain and Northern Ireland is among a number of concerns raised by industry executives at a recent hearing in the House of Lords.
Industry Warns Of New Post-Brexit ‘Cliff Edge’ For Medicines Supply To Northern Ireland
The burden of having to produce separate product packs for Great Britain and Northern Ireland is among a number of concerns raised by industry executives at a recent hearing in the House of Lords.
Brexit: ‘Enormous Complexity’ And ‘Significant Challenges’ Laid Bare
Speakers at a conference organized in Dublin by the Parenteral Drug Association spoke of the havoc wrought by the UK’s departure from the EU, and described how one company took steps to prepare for a no-deal Brexit, according to Ruaidhri O’Brien, who attended the event.